Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study investigator Edy Kornelius, M.D., Ph.D., of Chung Shan Medical University in Taichung, Taiwan
Tirzepatide at 5, 10, and 15 mg weekly produced superior HbA1c reductions compared to both placebo and active comparators including semaglutide
Just watch out for the added sugars
The consequence of misguided enforcement is that patients suffered as capable and law abiding consumers can no longer
Kim MK, et al
Mediation analysis for the relationship between urinary phthalate metabolites and type 2 diabetes via oxidative stress in a population in Jeddah, Saudi Arabia